Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Ortho-Clinical Diagnostics Inc. currently has 3 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are distributed among 3 distinct examiners, meaning each pending matter is being reviewed by a different individual. This distribution suggests a variety of examination perspectives for the company's current filings. The portfolio is concentrated within 2 distinct art units, indicating that multiple examiners are working within the same technical groups at the patent office.
The busiest examiner for the portfolio is SHIN, SOO JUNG, who is responsible for 1 busiest examiner pending action. Since there are 3 pending office actions and 3 distinct examiners, each examiner is responsible for a single action. This distribution across 3 distinct examiners within 2 distinct art units allows the company to receive feedback from different perspectives while remaining within 2 technical specialties. The 1 busiest examiner pending action for SHIN, SOO JUNG is a portion of the total pending workload.
In the Biotechnology & Pharmaceuticals sector, having 3 pending office actions in 2 distinct art units suggests a focused development of technology. The 3 distinct examiners provide diversity in the examination process. This structure for the 3 pending office actions means that the company must navigate the specific standards of 2 distinct art units while addressing the individual concerns of 3 distinct examiners, including SHIN, SOO JUNG.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (67%) |
| Double-patenting + other | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SHIN, SOO JUNG | 1 | 87.1% | +16.2% |
| BUCKMASTER, MARLENE VRENI | 1 | 25.8% | +78.1% |
| TSAY, MARSHA M | 1 | 45.7% | +52.7% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18937892 | SOFTWARE AND ALGORITHMS FOR USE IN REMOTE ASSESSMENT OF DISEASE DIAGNOSTICS | SHIN, SOO JUNG | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17539903 | LITHIUM HEPARIN AS A BLOCKING AGENT | BUCKMASTER, MARLENE VRENI | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16935867 | GLYCATED HEMOGLOBIN MEASUREMENT | TSAY, MARSHA M | 59d overdue |
| 18937892 | SOFTWARE AND ALGORITHMS FOR USE IN REMOTE ASSESSMENT OF DISEASE DIAGNOSTICS | SHIN, SOO JUNG | — |
| 17539903 | LITHIUM HEPARIN AS A BLOCKING AGENT | BUCKMASTER, MARLENE VRENI | — |
| Art Unit | Apps |
|---|---|
| 1672 | 1 |
| 1656 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18937892 | SOFTWARE AND ALGORITHMS FOR USE IN REMOTE ASSESSMENT OF DISEASE DIAGNOSTICS | SHIN, SOO JUNG | — | §102§103§112DP | Non-Final OA | — | Pending | Nov 05, 2024 |
| 17539903 | LITHIUM HEPARIN AS A BLOCKING AGENT | BUCKMASTER, MARLENE VRENI | 1672 | §103 | Non-Final OA | — | Pending | Dec 01, 2021 |
| 16935867 | GLYCATED HEMOGLOBIN MEASUREMENT | TSAY, MARSHA M | 1656 | §103 | Final Rejection | 59d overdue | Pending | Jul 22, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial